Inspiremd to report second quarter 2023 financial results and provide corporate business update on tuesday, august 8th

-conference call and webcast to be held at 8:30 a.m. edt- tel aviv, israel and miami, july 25, 2023 (globe newswire) -- inspiremd, inc. (nasdaq: nspr), developer of the cguard™ embolic prevention stent system (eps) device for the treatment of carotid artery disease and stroke prevention, announced today it will report second quarter 2023 financial results on tuesday, august 8thth, 2023, before the financial markets open.
NSPR Ratings Summary
NSPR Quant Ranking